Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 7/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | XIAP | P98170 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | ALPL | P05186 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.41 |
| ▸ | ANPEP | P15144 | 1/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16390246 | 0.80 | TSHR (0.53) | CYP1A2POLBCES1 | |
| SCHEMBL19025403 | 0.80 | ANPEP (0.44) | CPA1CYP1A2POLBANPEP | |
| SCHEMBL9672469 | 0.79 | FOLH1 (0.54) | TP53ANPEP | |
| Nitric Acid SCHEMBL9873353 | 0.79 | CPA1 (0.53) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL187342 | 0.78 | CPA1 (0.52) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL27952504 | 0.78 | TSHR (0.57) | CYP1A2POLBTP53SMN1; SMN2CES2 | |
| SCHEMBL6108470 | 0.78 | NR3C1 (0.45) | CYP1A2POLBNPC1RAB9A | |
| SCHEMBL8540021 | 0.77 | SLC15A1 (0.49) | CPA1ALPIPKMPTGS1XIAP | |
| SCHEMBL5610245 | 0.77 | CPA1 (0.50) | CPA1CYP1A2ALPIPKMPTGS1 | |
| SCHEMBL5981148 | 0.76 | CPA1 (0.50) | CPA1CYP1A2ALPIPKMPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025007135-A9 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | claimed |
| WO-2025007135-A2 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-01-02 | — | — | WO | claimed |
| CN-109126823-A | Nitrobenzene selective hydrogenation prepares the catalyst and preparation method, application of aniline | 江西理工大学 | 2019-01-04 | — | — | CN | claimed |
| CN-109053453-A | A kind of synthetic method of α-o-nitrophenylethanol | 江苏师范大学 | 2018-12-21 | — | — | CN | claimed |
| CN-108160094-A | A kind of N doping Carbon Materials support noble metal catalyst and preparation and application | 中国科学院大连化学物理研究所 | 2018-06-15 | — | — | CN | claimed |
| CN-107537565-A | Cross linked amphoteric polymeric supported precious metal catalyst and preparation and alcohol method for oxidation | 中国科学院大连化学物理研究所 | 2018-01-05 | — | — | CN | claimed |
| CN-105363394-B | A kind of preparation and application of the magnetic fluorescence molecular engram nanoparticle for detecting nitrobenzene | 济南大学 | 2017-11-07 | — | — | CN | claimed |
| EP-2486115-B1 | ELECTRORHEOLOGIC FLUID COMPRISING ORGANIC SUBSTANCES THAT CAN BE DOPED AND USE THEREOF | FRAUNHOFER GES FORSCHUNG (DE) | 2015-05-20 | — | — | EP | claimed |
| EP-2486115-A1 | ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF | Fraunhofer Gesellschaft zur Förderung der angewandten Wissenschaft E.V. (DE) | 2012-08-15 | — | — | EP | claimed |
| WO-2011042117-A1 | ELECTRORHEOLOGICAL FLUID COMPRISING ORGANIC DOPANTS, AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2011-04-14 | — | — | WO | claimed |
| EP-3808786-B1 | DEGRADABLE MICROSPHERE AND USE THEREOF | UNIV TSINGHUA (CN) | 2025-09-10 | — | — | EP | disclosed |
| US-12325767-B2 | Degradable microsphere and use thereof | TSINGHUA UNIVERSITY (CN) | 2025-06-10 | — | — | US | disclosed |
| WO-2025007135-A9 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-03-27 | — | — | WO | disclosed |
| WO-2025007135-A2 | CONTROLLED GLYCAN METABOLIC ENGINEERING SYSTEMS AND APPLICATIONS THEREOF | WAYNE STATE UNIVERSITY (US) | 2025-01-02 | — | — | WO | disclosed |
| CN-116676354-A | Method for synthesizing indigo and derivative thereof through double-enzyme cascade catalysis | 南京工业大学 | 2023-09-01 | — | — | CN | disclosed |
| US-4698340-A | TREATMENT OF CEREBROVASCULAR DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-06 | — | — | US | disclosed |
| US-4581178-A | USING TRANSITION METAL COMPLEXES CONTAINING PHOSPHINE OR ARSINE LI | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-04-08 | — | — | US | disclosed |
| EP-0169712-A2 | New pyrimidine derivatives, processes for preparation thereof and composition containing the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-01-29 | — | — | EP | disclosed |
| US-4374061-A | ACTIVATION, AMINATION, AND DIAZOTIZATION OF A POLYSACCHARIDE FOLLOWED BY REACTION WITH A GLOBULIN; CHROMATOGRAPHY; SEPARATION OF GLYCOPROTEINS | CENTER FOR BLOOD RESEARCH, INC. (US) | 1983-02-15 | — | — | US | disclosed |
| US-4299992-A | Process for the selective hydroxymethylation of nitrotoluenes | REANAL FINOMVEGYSZERGYAR (HU) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12325767-B2 | Degradable microsphere and use thereof | STUB1, PSMD14, ACP1 | CPA1 1447/4885CYP1A2 4564/4885ALPI 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.